Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -14.10% vs -3.29% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -72.28% vs 44.72% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 26.12% vs 57.72% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -36.55% vs 20.10% in Mar 2024
Compare Profit and Loss Results of Krebs Biochem
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
43.00
2.00
41.00
2,050.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
43.00
2.00
41.00
2,050.00%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-9.00
12.00
133.33%
Raw Materials Consumed
2.00
11.00
-9.00
-81.82%
Power & Fuel Cost
18.00
0.00
18.00
0%
Employee Cost
16.00
3.00
13.00
433.33%
Operating Expenses
12.00
0.00
12.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
58.00
9.00
49.00
544.44%
Operating Profit (PBDIT) excl Other Income
-15.00
-7.00
-8.00
-114.29%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
-14.00
-6.00
-8.00
-133.33%
Interest
5.00
2.00
3.00
150.00%
Profit before Depriciation and Tax
-20.00
-8.00
-12.00
-150.00%
Depreciation
6.00
0.00
6.00
0%
Profit Before Taxation & Exceptional Items
-26.00
-8.00
-18.00
-225.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-26.00
-8.00
-18.00
-225.00%
Provision for Tax
0.00
-1.00
1.00
100.00%
Profit After Tax
-26.00
-7.00
-19.00
-271.43%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-270.00
-14.00
-256.00
-1,828.57%
Profit Available for appropriations
-297.00
-22.00
-275.00
-1,250.00%
Appropriations
-297.00
-22.00
-275.00
-1,250.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-12.49
-2.06
-10.43
-506.31%
Profit And Loss - Net Sales
Net Sales 43.31 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -14.10% vs -3.29% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -15.03 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -72.28% vs 44.72% in Mar 2024
Profit And Loss - Interest
Interest 5.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 26.12% vs 57.72% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax -26.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -36.55% vs 20.10% in Mar 2024
